Friday 6 November 2026
Export PEN’s income statement to Excel — free account
Penumbra, Inc.
PEN Healthcare Medical Devices
Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.
- Revenue
- +15.6%
- EPS
- −8.29%
- Free cash flow
- −37.2%
- Total debt
- −10.3%
Quarter to September 2026, against a year earlier
319.20
1.91
−0.59%
Follow PEN
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 10.67% | 11.37% | 12.73% | 13.78% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 7 | 8 | |
| 8.33% | 8.80% | 9.80% | 10.58% | ||
ROIC |
12.73% | 13.13% | 13.32% | 13.09% | |
Return on Tangible Assets |
12.09% | 12.77% | 14.28% | 15.44% | |
Average Days of Receivables |
45.67 | 46.18 | 46.00 | 49.41 | |
Free Cash Flow per Share |
5.08 | 5.49 | 5.42 | 4.49 | |
Free Cash Flow |
200.29 | 215.91 | 212.73 | 174.93 | |
Capital Expenditures |
(60.75) | (61.90) | (63.93) | (63.73) | |
| Other line items | |||||
Cash ROIC |
8.80% | 9.77% | 10.08% | 8.78% | |
Accounts Receivable Turnover |
8.24 | 8.22 | 8.28 | 7.85 | |
Accounts Payable Turnover |
13.92 | 13.29 | 12.68 | 13.96 | |
Inventory Turnover |
1.12 | 1.11 | 1.11 | 1.10 | |
Average Days of Payables |
30.66 | 33.73 | 33.60 | 27.49 | |
Days of Inventory on Hand |
335.47 | 333.83 | 337.47 | 341.51 | |
Tax Rate |
(0.24) | (0.21) | (0.16) | (0.13) | |
Research and Development Expense of Revenue |
6.08% | 6.13% | 6.19% | 6.40% | |
Selling, General and Administrative Expense of Revenue |
49.77% | 49.26% | 48.32% | 47.26% | |
Share Based Compensation of Revenue |
3.74% | 3.95% | 4.13% | 4.22% | |
Operating CF/Net income |
1.66 | 1.73 | 1.62 | 1.34 | |
Depreciation/Fixed assets |
0.13 | 0.12 | 0.13 | 0.15 | |
Capex/Depreciation |
(3.02) | (3.61) | (3.75) | (3.65) | |
Revenue per Share |
39.60 | 38.24 | 37.03 | 36.07 | |
Operating CF per Share |
6.63 | 7.06 | 7.04 | 6.13 | |
Capex per Share |
(1.54) | (1.57) | (1.63) | (1.64) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026